share_log

Peeling Back The Layers: Exploring Travere Therapeutics Through Analyst Insights

アナリストの洞察によるTravere Therapeuticsの探求

Benzinga ·  03/13 10:00

Travere Therapeutics (NASDAQ:TVTX) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings21300
Last 30D10000
1M Ago01100
2M Ago00100
3M Ago10100

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $13.33, with a high estimate of $20.00 and a low estimate of $9.00. This upward trend is apparent, with the current average reflecting a 9.26% increase from the previous average price target of $12.20.

price target chart

Deciphering Analyst Ratings: An In...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする